Confo Therapeutics at PEGS Europe 2026

Nov 16–19, 2026 Lisbon, Portugal ~1.5k attendees Website

Confo Therapeutics brings 2 presentations to PEGS Europe 2026 in Lisbon. Its program covers antibody discovery against membrane targets and the part AI plays in it, plus an SSTR5 agonist for low blood sugar after bariatric surgery.

OrganizationPEGS Europe 2026 Attendance
Confo Therapeutics
Ghent, Belgium
confotherapeutics.com
Biotech
Develops medicines against G protein-coupled receptors using ConfoBodies, nanobodies that lock receptors in specific shapes for drug discovery.
Talk
Thu Nov 19
8:30am–9:00am
SSTR5 Agonist for Post-Bariatric Hypoglycemia
Antibodies Against Challenging Targets
Panel
Thu Nov 19
3:35pm–4:15pm
How is AI Facilitating the Discovery of Functional Antibodies Against Membrane Targets?
Antibodies Against Challenging Targets

Explore the full PEGS Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Lisbon. Leave your work email and we’ll be in touch.

Privacy

Download the full PEGS Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Confo Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by PEGS Europe or its organizers. Submit a correction